BackPHAXIAM Therapeutics S.A. Overview

PHAXIAM Therapeutics S.A. Current Assets

PHAXIAM Therapeutics S.A.'s current assets is $16M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$16.22M
↓ 61.96% YoYΔ $-26.41M vs prior year quarter

Peer trimmed avg / median

Loading

PHAXIAM Therapeutics S.A. Current Assets History

Loading

PHAXIAM Therapeutics S.A. vs. peers: Current Assets Comparison

Loading

PHAXIAM Therapeutics S.A. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

PHAXIAM Therapeutics S.A. (PHXM) FAQ

As of the most recent data (December 2023), PHXM shows a current assets of $16M. That compares with $43M in the prior-year period — down 62.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PHXM's current assets is now $16M (was $43M) — a 62.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether PHAXIAM Therapeutics S.A. is outperforming or lagging.

Tracking PHXM's current assets over time shows whether PHAXIAM Therapeutics S.A. is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $43M in the prior-year period — down 62.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has PHAXIAM Therapeutics S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $16M) with ownership activity and broader fundamentals.

PHAXIAM Therapeutics S.A.'s current assets is $16M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.